Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-08-28Clinical Trial Update: Prophylactic Ranibizumab for Exudative Age-Related Macular Degeneration [Phase 1, Phase 2]
Phase 1/2 trial evaluating prophylactic ranibizumab for exudative age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy [Phase 3]
A Phase 3 study evaluating Fovista (E10030) plus Lucentis versus Lucentis alone in age-related macular degeneration was terminated, with res…
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy [Phase 3]
A Phase 3 study evaluating the safety and efficacy of Fovista (E10030) in combination with Lucentis versus Lucentis alone for age-related ma…
-
CLINICAL_TRIALS trial_result · 2018-08-01Clinical Trial Update: Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical Trial [Phase 2, Phase 3]
A phase 2/3 trial is investigating whether combining propranolol with bevacizumab for intravitreal injection improves treatment response in …
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD) [Phase 2]
Phase 2 trial of intravitreal LFG316 in geographic atrophy and age-related macular degeneration has completed; results posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept [Phase 4]
Phase 4 trial comparing ranibizumab or bevacizumab to aflibercept for wet age-related macular degeneration; results have been posted.
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD) [Phase 1, Phase 2]
Clinical trial update reporting completed Phase 1/2 results for a study combining proton beam therapy with anti-VEGF therapy in exudative ag…
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD) [NA]
This document reports a completed 16-week evaluation of the Novartis Health Management Tool in patients with age-related macular degeneratio…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Palomid 529 in Patients With Neovascular Age-Related Macular Degeneration [Phase 1]
Phase 1 clinical trial update for Palomid 529 in neovascular age-related macular degeneration. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: Pilot Study of X-82 in Patients With Wet AMD [Phase 1, Phase 2]
Pilot study results for X-82 in wet age-related macular degeneration (exudative AMD) across Phase 1 and Phase 2 have been posted after trial…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: X-82 to Treat Age-related Macular Degeneration [Phase 2]
Phase 2 trial of X-82 for age-related macular degeneration has been terminated; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in Japan
A completed post-marketing surveillance study in Japan evaluating the AMD-QOL quality of life measure for patients with age-related macular …
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Single or Combined Protocols for NV-AMD [Phase 4]
This clinical trial update reports the completion of Phase 4 studies investigating single or combined protocols for neovascular age-related …
-
CLINICAL_TRIALS trial_result · 2018-05-23Clinical Trial Update: VITAL - Individualising Therapy for Neovascular AMD With Aflibercept [Phase 4]
Phase 4 trial update evaluating how aflibercept can be individualized to treat neovascular age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: Blood Coagulation Parameters in Patients Receiving Intravitreal Aflibercept for Age-related Macular Degeneration [NA]
This clinical trial update reports the completion of a study investigating blood coagulation parameters in patients receiving intravitreal a…
-
CLINICAL_TRIALS trial_result · 2018-05-03Clinical Trial Update: The Role of Macular Pigment in Patients With Age-related Macular Degeneration
This clinical trial update reports the completion of a study examining the role of macular pigment in age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2018-05-03Clinical Trial Update: CAPTAIN:Choroidal Neovascularization Assessment by Pattern Electroretinography [Phase 1]
This clinical trial update notes the completion of CAPTAIN, a Phase 1 study assessing choroidal neovascularization in age-related macular de…
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration [NA]
Clinical trial update indicating repeated injections of aflibercept for wet age-related macular degeneration has completed with results post…
-
CLINICAL_TRIALS trial_result · 2018-04-26Clinical Trial Update: The Effect of Eggs and Egg Products on Macular Pigment [NA]
A completed clinical trial investigated the effect of eggs and egg products on macular pigment in people with Age-related Macular Degenerati…
-
CLINICAL_TRIALS trial_result · 2018-04-24Clinical Trial Update: Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab Injections [Phase 4]
Phase 4 clinical trial evaluating intravitreal aflibercept for patients with incomplete response to ranibizumab in wet age-related macular d…
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration [Phase 2]
Phase 2 safety and efficacy study of DE-120 Injectable Solution for Age-related Macular Degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: A Phase I/II Safety Study of DE-120 Injectable Solution for Age-related Macular Degeneration [Phase 1, Phase 2]
This item reports the completion of a Phase I/II safety trial of DE-120 Injectable Solution for age-related macular degeneration conducted b…
-
CLINICAL_TRIALS trial_result · 2018-04-13Clinical Trial Update: Technology-based Eye Care Services (TECS) Compare [NA]
A completed clinical trial assessing Technology-based Eye Care Services (TECS) for eye conditions such as cataract, macular degeneration, an…
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: CEI Van Outreach Screening Study
The CEI Van Outreach Screening Study sponsored by Oregon Health and Science University has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-10Clinical Trial Update: The Association of the Peripheral Retinal Changes and Genotypic Changes in Patients With Age Related Macular Degeneration
This completed clinical trial study investigates the association between peripheral retinal changes and genotypic variations in patients wit…